©2013 Baishideng Publishing Group Co.
World J Nephrol. Aug 6, 2013; 2(3): 56-76
Published online Aug 6, 2013. doi: 10.5527/wjn.v2.i3.56
Published online Aug 6, 2013. doi: 10.5527/wjn.v2.i3.56
Table 2 Development of Shiga-toxin-associated hemolytic uremic syndrome
| Pathogenetic steps | Clinical |
| Ingestion of Escherichia Coli through contaminated food or patient to patient transmission or transmission from animal to man | Colonization of the gut |
| Diarrhoea | Local tissue damage |
| Bloody diarrhoea | Systemic toxinemia |
| Generation of host cytokines and chemokines | Endothelia cell damage, activation of local thrombosis in kidneys and in other organs |
| Renal involvement→ HUS | Damage to glomerular endothelial cells, arteriolar damage, mesangial cell activation/damage, podocyte injury, tubular damage |
| Renal Insufficiency | Acute renal failure |
| Chronic renal failure | |
| Arterial hypertension, proteinuria, hematuria |
- Citation: Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56-76
- URL: https://www.wjgnet.com/2220-6124/full/v2/i3/56.htm
- DOI: https://dx.doi.org/10.5527/wjn.v2.i3.56